Bactana Animal Health, a company developing natural products aimed at reducing the use of antibiotics and hormones in the world’s food supply through enhancement of the gut microbiota, has announced the closing of its first round of funding.

Investors in the round included Connecticut Innovations; New York-based Sustainable Income Capital Management, LLC; and a number of private investors. The company says it will use the financing proceeds to complete additional studies using its FPS-4™ product platform, hire personnel, establish commercial manufacturing capabilities, and prepare for its initial global product launch.